NRC Health Shareholders' Equity
NRC Health (NRC) had Shareholders' Equity of $6.55 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-04
- 2026-06-30: Stockholders' Equity Attributable to Parent $6.55M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $13.49M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $13.99M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $14.31M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $6.55M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $13.49M 10-Q · filed 2026-08-04 |
| 2025-12-31 | $13.99M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $14.31M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $21.33M 10-Q · filed 2026-08-04 |
| 2025-03-31 | $29.67M 10-Q · filed 2026-08-04 |
| 2024-12-31 | $31.28M 10-Q · filed 2026-08-04 |
| 2024-09-30 | $34.62M 10-Q · filed 2025-11-07 |
| 2024-06-30 | $40.20M 10-Q · filed 2025-11-07 |
| 2024-03-31 | $36.95M 10-Q · filed 2025-11-07 |
| 2023-12-31 | $48.95M 10-K · filed 2026-03-05 |
| 2023-09-30 | $57.87M 10-Q · filed 2024-11-08 |
| 2023-06-30 | $77.75M 10-Q · filed 2024-11-08 |
| 2023-03-31 | $74.67M 10-Q · filed 2024-11-08 |
| 2022-12-31 | $72.03M 10-K · filed 2026-03-05 |
| 2022-09-30 | $67.77M 10-Q · filed 2023-11-09 |
| 2022-06-30 | $68.62M 10-Q · filed 2023-11-09 |
| 2022-03-31 | $81.49M 10-Q · filed 2023-11-09 |
| 2021-12-31 | $85.34M 10-K · filed 2025-03-17 |
| 2021-09-30 | $83.13M 10-Q · filed 2022-11-04 |
| 2021-06-30 | $76.36M 10-Q · filed 2022-11-04 |
| 2021-03-31 | $73.25M 10-Q · filed 2022-11-04 |
| 2020-12-31 | $64.31M 10-K · filed 2024-02-27 |
| 2020-09-30 | $56.73M 10-Q · filed 2021-11-05 |
| 2020-06-30 | $45.57M 10-Q · filed 2021-11-05 |
| 2020-03-31 | $37.30M 10-Q · filed 2021-11-05 |
| 2019-12-31 | $32.89M 10-K · filed 2023-03-03 |
| 2019-09-30 | $28.98M 10-Q · filed 2020-11-06 |
| 2019-06-30 | $25.97M 10-Q · filed 2020-11-06 |
| 2019-03-31 | $22.74M 10-Q · filed 2020-11-06 |
| 2018-12-31 | $19.08M 10-K · filed 2022-03-04 |
| 2018-09-30 | $30.14M 10-Q · filed 2019-11-08 |
| 2018-06-30 | $26.82M 10-Q · filed 2019-11-08 |
| 2018-03-31 | $95.36M 10-Q · filed 2019-11-08 |
| 2017-12-31 | $90.04M 10-K · filed 2021-03-05 |
| 2017-09-30 | $88.84M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $87.83M 10-Q · filed 2017-08-04 |
| 2017-03-31 | $85.57M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $82.81M 10-K · filed 2020-03-06 |
| 2016-09-30 | $81.22M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $79.66M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $76.17M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $74.22M 10-K · filed 2019-03-08 |
| 2015-09-30 | $86.59M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $89.69M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $87.84M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $87.75M 10-K · filed 2018-03-14 |
| 2013-12-31 | $71.75M 10-K · filed 2017-03-03 |
| 2012-12-31 | $56.74M 10-K · filed 2016-03-04 |
| 2011-12-31 | $55.55M 10-K · filed 2015-03-04 |
| 2010-12-31 | $48.58M 10-K · filed 2014-03-04 |
| 2009-12-31 | $44.17M 10-K · filed 2013-03-01 |
| 2008-12-31 | $38.60M 10-K · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |